Tradestie Institutional Equity Comparison Engine
ACAD vs CRSP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACAD Overall Edge
ACAD Captures Institutional Edge (4โ0 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Acadia Pharmaceuticals Inc. (ACAD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ACAD trades at 17.8x Forward P/E with 10.2% operating margin (+22.8% YoY revenue) versus CRSP at 23.4x Forward P/E and -2058.6% operating margin (+1325.1% YoY). In options structure, ACAD sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against CRSP sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ACAD
ACAD 17.8x vs CRSP 23.4x Fwd P/E
Growth & Margin Winner
ACAD
Op Margin 10.2% vs -2058.6% ยท YoY +22.8% vs +1325.1%
Momentum & Technical Winner
ACAD
1Y -19.3% vs -20.5% ยท 52W Pos 21% vs 1%
Options & Structure Winner
ACAD
BREAKDOWN (4th %ile IV) vs BREAKDOWN (52nd %ile IV)
ACAD
NASDAQ
Acadia Pharmaceuticals Inc.
Pharmaceutical Preparations
$19.07
+1.71% 1D
Market Cap
$3.1B
1M Return
-0.26%
1Y Return
-19.33%
Forward P/E
17.8x
Unified AI Score
42.0 / 100
HOLD
Tech 43.0
Fund 52.0
Flow 68.0
Mom 50.0
CRSP
NASDAQ
CRISPR Therapeutics AG
Biological Products, (No Disgnostic Substances)
$40.61
-3.86% 1D
Market Cap
$4.1B
1M Return
-17.54%
1Y Return
-20.54%
Forward P/E
23.4x
Unified AI Score
44.7 / 100
HOLD
Tech 25.0
Fund 52.0
Flow 68.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ACAD -19.33%
CRSP -20.54%
Spread: +1.21 pp (ACAD Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ACAD Revenue | CRSP Revenue | ACAD Op. Margin | CRSP Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $220M | $0M | -110.6% | -5087.8% | ACAD |
| FY2019 | $340M | $290M | -72.7% | 16.1% | CRSP |
| FY2020 | $440M | $0M | -64.9% | -49295.5% | ACAD |
| FY2021 | $480M | $910M | -35.2% | 40.8% | CRSP |
| FY2022 | $520M | $0M | -43.2% | -56190.4% | ACAD |
| FY2023 | $730M | $370M | -10.1% | -60.0% | ACAD |
| FY2024 | $960M | $40M | 24.1% | -1250.4% | ACAD |
| FY2025 | $1.07B | $0M | 9.8% | -18933.6% | ACAD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACAD | CRSP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.1B | $4.1B | Larger Scale | CRSP |
| Trailing P/E Ratio Valuation | 8.6x | 23.4x | Lower Multiple | ACAD |
| Forward P/E Ratio Valuation | 17.8x | 23.4x | Lower Multiple | ACAD |
| Revenue Growth (YoY) Growth | +22.8% | +1325.1% | Higher Growth | CRSP |
| Operating Margin (TTM) Profitability | 10.2% | -2058.6% | Higher Margin | ACAD |
| Net Profit Margin Profitability | 30.1% | 0.0% | Higher Margin | ACAD |
| Return on Equity (ROE) Capital Efficiency | 31.4% | -25.6% | Higher ROE | ACAD |
| 52-Week Range Position Momentum | 21% ($16โ$31) | 1% ($40โ$63) | Stronger Trend | ACAD |
| Beta / 30D Volatility Risk Regime | 0.11ฮฒ ยท 93% Vol | 1.85ฮฒ ยท 60% Vol | Lower Realized Risk | CRSP |
| Unified Institutional Score Composite Signal | 42.0 / 100 (HOLD) | 44.7 / 100 (HOLD) | Higher Composite | CRSP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ACAD vs CRSP Buy Guide
ACAD
BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
CRSP
BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
52nd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ACAD nor CRSP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.